These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bone biopsy results and serum bone turnover parameters in uremic children. Ziólkowska H, Pańiczyk-Tomaszewska M, Debiński A, Polowiec Z, Sawicki A, Sieniawska M. Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959 [Abstract] [Full Text] [Related]
8. Bone mineral and aluminum concentrations in patients undergoing CAPD. Giangrande A, Costanini S, Ballanti P, Castiglioni A, Caligara F, Pisoni B, Giordano R, Vernillo I, Berni S, Bonucci E. Adv Perit Dial; 1992 Jun; 8():351-5. PubMed ID: 1361821 [Abstract] [Full Text] [Related]
10. Vitamin D therapy in CAPD: what is its role? Hutchison AJ, Gokal R. Adv Perit Dial; 1993 Jun; 9():253-6. PubMed ID: 8105937 [Abstract] [Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
17. Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis. Chan HW, Tsang WK, Chan CM, Fung SK, So SO, Tang HL, Tong MK, Lee KC, Chan AY. Perit Dial Int; 1998 Nov; 18(2):177-82. PubMed ID: 9576366 [Abstract] [Full Text] [Related]
18. Diagnosis and management of bone disorders in chronic renal failure and dialyzed patients. Tzamaloukas AH. Med Clin North Am; 1990 Jul; 74(4):961-74. PubMed ID: 2195265 [Abstract] [Full Text] [Related]
19. Pulse oral calcitriol to treat hyperparathyroidism in 43 CAPD patients. Juergensen P, Santacroce S, Mooraki A, Cooper K, Finkelstein FO, Kliger AS. Adv Perit Dial; 1994 Jul; 10():259-60. PubMed ID: 7999840 [Abstract] [Full Text] [Related]